Zacks Research Estimates Equifax's Q3 Earnings (NYSE:EFX)

Key Points

• Zacks Research forecasts Equifax Q3 2028 EPS of $2.81; the article also notes analyst reductions to several full-year earnings forecasts, including FY2027 and FY2028.
• In its latest reported quarter, Equifax earned $2.26 per share, beating the $2.20 consensus. Revenue of $1.69 billion matched estimates and rose 9.6% year over year.
• Analyst sentiment is moderately positive: 14 analysts rate the stock a Buy and seven a Hold, for an average price target of $200.55.

Equifax, Inc. (NYSE:EFX - Free Report) - Investment analysts at Zacks Research issued their Q3 2028 earnings per share (EPS) estimates for shares of Equifax in a research note issued on Tuesday, November 3rd. Zacks Research analyst Team forecasts that the credit services provider will earn $2.81 per share for the quarter. The consensus estimate for Equifax's current full-year earnings is $8.50 per share.

Equifax (NYSE:EFX - Get Free Report) last announced its earnings results on Tuesday, October 20th. The credit services provider reported $2.26 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.20 by $0.06. The firm had revenue of $1.69 billion during the quarter, compared to analyst estimates of $1.69 billion. Equifax had a return on equity of 22.48% and a net margin of 11.27%. The business's revenue was up 9.6% compared to the same quarter last year. During the same period last year, the firm posted $2.04 EPS.

A number of other research analysts have also recently weighed in on the stock. Weiss Ratings upgraded shares of Equifax from a "sell (d+)" rating to a "hold (c-)" rating in a research note on Thursday, August 13th. Barclays reduced their target price on shares of Equifax from $200.00 to $155.00 and set an "equal weight" rating for the company in a research report on Friday, October 2nd. Loop Capital set a $169.00 price target on shares of Equifax in a research note on Tuesday, October 20th. Citigroup lowered their price target on shares of Equifax from $238.00 to $220.00 and set a "buy" rating on the stock in a report on Wednesday, July 22nd. Finally, BMO Capital Markets upped their price objective on Equifax from $160.00 to $175.00 and gave the company a "market perform" rating in a research note on Wednesday, October 21st. Fourteen analysts have rated the stock with a Buy rating and seven have issued a Hold rating to the stock. Based on data from MarketBeat.com, the company currently has an average rating of "Moderate Buy" and an average price target of $200.55.

Equifax Price Performance

EFX opened at $192.31 on Thursday. The firm has a market cap of $22.50 billion, a P/E ratio of 31.07, a PEG ratio of 1.92 and a beta of 1.27. The firm has a 50-day moving average of $166.25 and a 200 day moving average of $177.01. The company has a debt-to-equity ratio of 1.12, a quick ratio of 1.09 and a current ratio of 1.09. Equifax has a fifty-two week low of $137.01 and a fifty-two week high of $228.67.

Institutional Trading of Equifax

Institutional investors have recently modified their holdings of the business. Raiffeisen Bank International AG increased its position in shares of Equifax by 1.5% during the second quarter. Raiffeisen Bank International AG now owns 3,590 shares of the credit services provider's stock valued at $569,000 after buying an additional 53 shares during the period. Axiom Investment Management LLC lifted its holdings in shares of Equifax by 8.9% in the third quarter. Axiom Investment Management LLC now owns 670 shares of the credit services provider's stock worth $92,000 after buying an additional 55 shares in the last quarter. V Square Quantitative Management LLC lifted its holdings in shares of Equifax by 3.8% in the first quarter. V Square Quantitative Management LLC now owns 1,730 shares of the credit services provider's stock worth $312,000 after buying an additional 64 shares in the last quarter. Aprio Wealth Management LLC boosted its position in shares of Equifax by 6.2% in the third quarter. Aprio Wealth Management LLC now owns 1,682 shares of the credit services provider's stock valued at $231,000 after acquiring an additional 98 shares during the period. Finally, Droms Strauss Advisors Inc. MO ADV boosted its position in shares of Equifax by 1.9% in the first quarter. Droms Strauss Advisors Inc. MO ADV now owns 5,435 shares of the credit services provider's stock valued at $979,000 after acquiring an additional 100 shares during the period. 96.20% of the stock is currently owned by hedge funds and other institutional investors.

Insider Activity

In other Equifax news, EVP John W. Gamble, Jr. sold 4,000 shares of the stock in a transaction dated Thursday, October 29th. The shares were sold at an average price of $177.68, for a total transaction of $710,720.00. Following the completion of the transaction, the executive vice president owned 65,145 shares in the company, valued at $11,574,963.60. This trade represents a 5.78% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Mark Begor sold 37,792 shares of the stock in a transaction dated Friday, October 23rd. The stock was sold at an average price of $182.80, for a total transaction of $6,908,377.60. Following the transaction, the chief executive officer owned 289,922 shares of the company's stock, valued at $52,997,741.60. This represents a 11.53% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last ninety days, insiders have sold 46,292 shares of company stock worth $8,464,918. Insiders own 1.70% of the company's stock.

Equifax Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, September 15th. Shareholders of record on Monday, August 31st were issued a dividend of $0.56 per share. The ex-dividend date of this dividend was Monday, August 31st. This represents a $2.24 annualized dividend and a yield of 1.2%. Equifax's dividend payout ratio is 36.19%.

Key Headlines Impacting Equifax

Here are the key news stories impacting Equifax this week:

• Positive Sentiment: Zacks Research modestly raised its Q2 2028 EPS estimate to $2.81 from $2.79, offering a limited positive signal. Equifax analyst estimates
• Neutral Sentiment: An Equifax survey found that rising costs are affecting how Canadians manage credit, with younger adults and families worried about financial milestones. It highlights consumer pressure but does not quantify an impact on Equifax’s results. Equifax survey on financial health
• Negative Sentiment: Zacks Research cut several forecasts: FY2026 EPS to $8.49 from $8.63, FY2027 to $9.33 from $9.84, and FY2028 to $10.72 from $10.95. Estimates for multiple coming quarters were also reduced, including Q1 2027 to $1.98 from $2.12. The broad revisions suggest a softer earnings outlook, although the FY2026 estimate remains close to the $8.50 consensus cited in the reports. Equifax analyst estimates
• Negative Sentiment: EVP John Gamble Jr. sold 4,000 shares for about $711,000. The sale was made under a pre-arranged trading plan, and he retained a substantial holding, which may temper the signal. Equifax insider sale

Equifax Company Profile

Equifax Inc NYSE: EFX is a global data, analytics and technology company that provides information and services to help businesses, governments and consumers make informed financial and workforce decisions. The company is best known for its credit reporting activities, but its offerings also include identity verification, fraud prevention, income and employment verification, marketing services and risk management solutions.

Equifax provides consumer and commercial credit information, credit reports and related analytics to lenders and other businesses.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.